Christopher L. Bowlus

16.5k citations
231 papers · 8.9k indexed · 4 hit papers · h-index 53
Topics
Liver Diseases and Immunity (156 papers)Liver Disease Diagnosis and Treatment (111 papers)Pediatric Hepatobiliary Diseases and Treatments (52 papers)

In The Last Decade

Christopher L. Bowlus

217 papers receiving 8.7k citations

Hit Papers

Exenatide effects on diabetes, obesity, cardiovascular ri...20072026201320192007201820192022100200300400500

Peers

Christopher L. Bowlus
Comparison fields: 5 of 137
  • Hepatology 4.9k
  • Epidemiology 4.0k
  • Surgery 3.2k
  • Oncology 1.2k
  • Molecular Biology 1.2k
Replace Elwyn Elias with:
Elwyn Elias United Kingdom
Paolo Geñtilini Italy
Peter F. Whitington United States
Maria Isabel Fiel United States
Henning Grønbæk Denmark
David Cassiman Belgium
Ulrich Beuers Netherlands
Shuhei Nishiguchi Japan
Marlon F. Levy United States
Hiromasa Ohira Japan
Christopher L. Bowlus relative to Elwyn Elias United Kingdom Elwyn Elias's profile →
Citations per field
00.5×7.5×
Elwyn Elias · 1×
Citations per year

Countries citing papers authored by Christopher L. Bowlus

Since Specialization
Citations

This map shows the geographic impact of Christopher L. Bowlus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Bowlus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Bowlus more than expected).

Fields of papers citing papers by Christopher L. Bowlus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher L. Bowlus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Bowlus. The network helps show where Christopher L. Bowlus may publish in the future.

Co-authorship network of co-authors of Christopher L. Bowlus

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Bowlus. A scholar is included among the top collaborators of Christopher L. Bowlus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Bowlus. Christopher L. Bowlus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 11
4 1
5 3
6 0
7 14
8 22
9 22
10 6
11 0
12 14
13 63
14 35
15 28
16
The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC.
3
17 70
18 16
19
Hepatic expression of lysyl oxidase-like-2 ( LOXL2) in primary sclerosing cholangitis (PSC)
3
20 128

About Christopher L. Bowlus

Christopher L. Bowlus is a scholar working on Hepatology, Epidemiology and Surgery, having authored 231 papers that have together received 8.9k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (156 papers), Liver Disease Diagnosis and Treatment (111 papers) and Pediatric Hepatobiliary Diseases and Treatments (52 papers). The work is most often cited by research in Hepatology (4.9k citations), Epidemiology (4.0k citations) and Surgery (3.2k citations). Christopher L. Bowlus has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include M. Eric Gershwin, Cynthia Levy, Keith D. Lindor, Ross L. Coppel, Marlyn J. Mayo, John H. Holcombe, Matthew Wintle, John B. Buse, David C. Klonoff and Loretta L. Nielsen. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026